Your browser doesn't support javascript.
loading
Enfermedad inflamatoria intestinal: Una mirada inmunológica: [revisión] / Inflammatory bowel diseases: An immunological approach: [review]
Sepúlveda, Sofía E; Beltrán, Caroll J; Peralta, Alexis; Rivas, Paola; Rojas, Néstor; Figueroa, Carolina; Quera, Rodrigo; Hermoso, Marcela A.
  • Sepúlveda, Sofía E; Universidad de Chile. Instituto de Ciencias Biomédicas. Santiago. CL
  • Beltrán, Caroll J; Universidad de Chile. Facultad de Medicina. Instituto de Ciencias Biomédicas. Programa Disciplinario de Inmunología. CL
  • Peralta, Alexis; Universidad de Chile. Santiago. CL
  • Rivas, Paola; Universidad de Chile. Santiago. CL
  • Rojas, Néstor; Universidad de Chile. Santiago. CL
  • Figueroa, Carolina; Universidad de Chile. Hospital Clínico. Departamento de Medicina Interna. CL
  • Quera, Rodrigo; Universidad de Chile. Hospital Clínico. Sección de Gastroenterología. CL
  • Hermoso, Marcela A; Universidad de Chile. Facultad de Medicina. Instituto de Ciencias Biomédicas. Programa Disciplinario de Inmunología. CL
Rev. méd. Chile ; 136(3): 367-375, mar. 2008. ilus
Article in Spanish | LILACS | ID: lil-484909
ABSTRACT
Inflammatory bowel diseases (IBD) are inflammatory diseases with a multifactorial component that involve the intestinal tract. The two relevant IBD syndromes are Crohn's disease (CD) and ulcerative colitis (UC). One factor involved in IBD development is a genetic predisposition, associated to NOD2/CARD15 and Toll-like receptor 4 (TLR4) polymorphisms that might favor infectious enterocolitis that is possibly associated to the development of IBD. The identification of specific immunologic alterations in IBD and their relationship to the etiology of the disease is a relevant research topic. The role of intra and extracellular molecules, such as transcription factors and cytokines that are involved in the inflammatory response, needs to be understood. The relevance of immunologic molecules that might drive the immune response to a T helper (Th) 1, Th 2 or the recently described Th 17 phenotype, has been demonstrated in animal models and clinical studies with IBD patients. CD and UC predominantly behave with a Th 1 and Th 2 immune phenotype, respectively. Recently, an association between CD and Th 17 has been reported. The knowledge acquired from immunologic and molecular research will help to develop accurate diagnostic methods and efficient therapies.
Subject(s)

Full text: Available Index: LILACS (Americas) Main subject: Inflammatory Bowel Diseases Type of study: Diagnostic study / Prognostic study Limits: Humans Language: Spanish Journal: Rev. méd. Chile Journal subject: Medicine Year: 2008 Type: Article / Project document Affiliation country: Chile Institution/Affiliation country: Universidad de Chile/CL

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Inflammatory Bowel Diseases Type of study: Diagnostic study / Prognostic study Limits: Humans Language: Spanish Journal: Rev. méd. Chile Journal subject: Medicine Year: 2008 Type: Article / Project document Affiliation country: Chile Institution/Affiliation country: Universidad de Chile/CL